StockNews.com assumed coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a report issued on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
VBI Vaccines Price Performance
Shares of VBIV opened at $0.02 on Friday. VBI Vaccines has a 1-year low of $0.06 and a 1-year high of $1.35. The firm has a 50 day simple moving average of $0.34 and a 200-day simple moving average of $0.51.
VBI Vaccines Company Profile
Further Reading
- Five stocks we like better than VBI Vaccines
- Basic Materials Stocks Investing
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Introduction to Fibonacci Retracement Levels
- What Is WallStreetBets and What Stocks Are They Targeting?
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.